Iqvia price target raised to $290 from $285 at BTIG

BTIG raised the firm’s price target on Iqvia to $290 from $285 and keeps a Buy rating on the shares after its Q4 earnings beat. The company delivered $2.8B in new bookings, which is the second-highest quarterly result in the history of the company, and on the earnings call, the management highlighted that the pace of R&D RFP, bookings, and pipeline continues to be very robust, the analyst tells investors in a research note.